These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24283835)

  • 1. New therapeutic could help prevent hypersensitive allergic reactions.
    Wilkinson J
    Immunotherapy; 2013 Dec; 5(12):1275. PubMed ID: 24283835
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoglobulin-like receptor, allergin-1 regulates the activation of mast cells].
    Tahara-Hanaoka S; Shibuya A
    Arerugi; 2013 Nov; 62(11):1451-7. PubMed ID: 24552759
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibitory effect of eriodictyol on IgE/Ag-induced type I hypersensitivity.
    Yoo JM; Kim JH; Park SJ; Kang YJ; Kim TJ
    Biosci Biotechnol Biochem; 2012; 76(7):1285-90. PubMed ID: 22785465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE-mediated hypersensitivity reactions.
    Fadal RG
    Otolaryngol Head Neck Surg; 1993 Sep; 109(3 Pt 2):565-78. PubMed ID: 8414585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspergillus oryzae lectin induces anaphylactoid oedema and mast cell activation through its interaction with fucose of mast cell-bound non-specific IgE.
    Yamaki K; Yoshino S
    Scand J Immunol; 2011 Nov; 74(5):445-53. PubMed ID: 21790704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract.
    Ladics GS; van Bilsen JH; Brouwer HM; Vogel L; Vieths S; Knippels LM
    Regul Toxicol Pharmacol; 2008 Aug; 51(3):288-94. PubMed ID: 18534732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate hypersensitivity elicits renin release from cardiac mast cells.
    Kano S; Tyler E; Salazar-Rodriguez M; Estephan R; Mackins CJ; Veerappan A; Reid AC; Silver RB; Levi R
    Int Arch Allergy Immunol; 2008; 146(1):71-5. PubMed ID: 18087164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Eosinophilic allergens: immunopathology and therapeutic approaches].
    Polla BS
    Rev Med Suisse Romande; 1993 Mar; 113(3):169-72. PubMed ID: 7683138
    [No Abstract]   [Full Text] [Related]  

  • 9. What potential do heterobivalent inhibitors have for the treatment of severe allergic reactions?
    Handlogten MW; Serezani AP; Kaplan MH; Bilgicer B
    Immunotherapy; 2014; 6(3):223-5. PubMed ID: 24762067
    [No Abstract]   [Full Text] [Related]  

  • 10. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge.
    Christensen LH; Holm J; Lund G; Riise E; Lund K
    J Allergy Clin Immunol; 2008 Aug; 122(2):298-304. PubMed ID: 18572230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells.
    Inoue T; Katoh N; Kishimoto S
    Acta Derm Venereol; 2006; 86(1):13-6. PubMed ID: 16585982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in understanding and therapy of allergic immediate hypersensitivity with antihistaminics].
    Merk HF
    Wien Med Wochenschr; 1994; 144(4):88-92. PubMed ID: 8023528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of IgE-mediated allergic reactions.
    Bloebaum RM; Dharajiya N; Grant JA
    Clin Allergy Immunol; 2004; 18():65-84. PubMed ID: 15042909
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of an in vitro system for the study of allergens and allergen-specific immunoglobulin E and immunoglobulin G: Fcepsilon receptor I supercross-linking is a possible new mechanism of immunoglobulin G-dependent enhancement of type I allergic reactions.
    Sellge G; Laffer S; Mierke C; Vrtala S; Hoffmann MW; Klempnauer J; Manns MP; Valenta R; Bischoff SC
    Clin Exp Allergy; 2005 Jun; 35(6):774-81. PubMed ID: 15969669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isodon japonicus decreases immediate-type allergic reaction and tumor necrosis factor-alpha production.
    Shin TY; Kim SH; Choi CH; Shin HY; Kim HM
    Int Arch Allergy Immunol; 2004 Sep; 135(1):17-23. PubMed ID: 15286441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein and Antibody Engineering: Suppressing Degranulation of the Mast Cells and Type I Hypersensitivity Reaction.
    Rajani HF; Shahidi S; Gomari MM
    Curr Protein Pept Sci; 2020; 21(8):831-841. PubMed ID: 32392111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
    Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS
    Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional analyses before and after suppression of immediate hypersensitivity reactions by CCR3 blockade in eyes with experimental allergic conjunctivitis.
    Komatsu N; Miyazaki D; Tominaga T; Kuo CH; Namba S; Takeda S; Higashi H; Inoue Y
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5307-13. PubMed ID: 18658092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic treatment of whey proteins in cow's milk results in differential inhibition of IgE-mediated mast cell activation compared to T-cell activation.
    Knipping K; van Esch BC; van Ieperen-van Dijk AG; van Hoffen E; van Baalen T; Knippels LM; van der Heide S; Dubois AE; Garssen J; Knol EF
    Int Arch Allergy Immunol; 2012; 159(3):263-70. PubMed ID: 22722685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.